GTS Securities’s Checkpoint Therapeutics CKPT Stock Holding History

GTS Securities’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-35,000	Closed	-$141K	–	1280
2025 Q1	$141K	Buy	+35,000	New	+$117K	0.01%	1165

GTS Securities's CKPT Position: Q2 2025 in Review

GTS Securities sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 35,000 shares — an estimated $141K sold.

GTS Securities first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $141K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

GTS Securities reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
GTS Securities sold 35,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $141K.
GTS Securities first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
GTS Securities's Checkpoint Therapeutics position peaked at $141K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on GTS Securities's 13F filing for Q2 2025, filed 8 Aug 2025.